TNYA stock icon

Tenaya Therapeutics
TNYA

$3.64
4.21%

Market Cap: 286M

 

About: Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and precision medicine.

Employees: 140

0
Funds holding %
of 6,702 funds
0
Analysts bullish %
of 6 analysts
News positive %

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

4,767% more call options, than puts

Call options by funds: $292K | Put options by funds: $6K

175% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 8

93% more capital invested

Capital invested by funds: $151M [Q4 2023] → $292M (+$140M) [Q1 2024]

19% more funds holding

Funds holding: 74 [Q4 2023] → 88 (+14) [Q1 2024]

2.53% more ownership

Funds ownership: 68.57% [Q4 2023] → 71.09% (+2.53%) [Q1 2024]

4% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 26

33% less funds holding in top 10

Funds holding in top 10: 3 [Q4 2023] → 2 (-1) [Q1 2024]

Research analyst outlook

6 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$16
340%
upside
Avg. target
$18
395%
upside
High target
$20
449%
upside

6 analyst ratings

positive
100%
neutral
0%
negative
0%
HC Wainwright & Co.
Joseph Pantginis
395%upside
$18
Buy
Reiterated
8 Jul 2024
Canaccord Genuity
Whitney Ijem
340%upside
$16
Buy
Maintained
16 May 2024
HC Wainwright & Co.
Joseph Pantginis
395%upside
$18
Buy
Reiterated
15 May 2024
Chardan Capital
Geulah Livshits
449%upside
$20
Buy
Reiterated
21 Mar 2024
Canaccord Genuity
Whitney Ijem
395%upside
$18
Buy
Maintained
20 Mar 2024

Financial journalist opinion